Intra-Cellular Therapies
(NASDAQ:ITCI)
55.62
-1.57[-2.75%]
At close: Jun 24
55.62
00
After Hours: 5:17PM EDT
Day High/Low55.26 - 58.51
52 Week High/Low28.4 - 66
Open / Close57.83 / 55.62
Float / Outstanding82M / 94.3M
Vol / Avg.1.6M / 888.1K
Mkt Cap5.2B
P/E-
50d Avg. Price55.36
Div / Yield-
Payout Ratio-
EPS-0.78
Total Float82M

Intra-Cellular Therapies (NASDAQ:ITCI), Quotes and News Summary

Intra-Cellular Therapies (NASDAQ: ITCI)

Day High/Low55.26 - 58.51
52 Week High/Low28.4 - 66
Open / Close57.83 / 55.62
Float / Outstanding82M / 94.3M
Vol / Avg.1.6M / 888.1K
Mkt Cap5.2B
P/E-
50d Avg. Price55.36
Div / Yield-
Payout Ratio-
EPS-0.78
Total Float82M
load more
Sector: Health Care.Industry: Pharmaceuticals
Intra-Cellular Therapies Inc is a biopharmaceutical company that develops novel drugs for treating diseases of the central nervous system. The company is focused on the delivery and clinical development of small-molecule drugs that address needs in neuropsychiatric and neurological disorders. Intra-Cellular maintains proprietary chemistry platforms to develop drugs for neurodegenerative diseases. The company's business segment is discovering and developing drugs for the treatment of neurological and psychiatric disorders.

Earnings

see more
Q2 2022Est.ActualSurprise
EPS
(EXPECTED)2022-08-08
REV
Q1 2022Est.ActualSurprise
EPS-0.920-0.780 0.1400
REV33.650M34.996M1.346M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Intra-Cellular Therapies Questions & Answers

Q
How do I buy Intra-Cellular Therapies (ITCI) stock?
A

You can purchase shares of Intra-Cellular Therapies (NASDAQ: ITCI) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are Intra-Cellular Therapies's (ITCI) competitors?
Q
What is the target price for Intra-Cellular Therapies (ITCI) stock?
A

The latest price target for Intra-Cellular Therapies (NASDAQ: ITCI) was reported by UBS on Tuesday, June 14, 2022. The analyst firm set a price target for 75.00 expecting ITCI to rise to within 12 months (a possible 34.84% upside). 13 analyst firms have reported ratings in the last year.

Q
Current Stock Price for Intra-Cellular Therapies (ITCI)?
A

The stock price for Intra-Cellular Therapies (NASDAQ: ITCI) is $55.62 last updated June 24, 2022, 8:00 PM UTC.

Q
Does Intra-Cellular Therapies (ITCI) pay a dividend?
A

There are no upcoming dividends for Intra-Cellular Therapies.

Q
When is Intra-Cellular Therapies (NASDAQ:ITCI) reporting earnings?
A

Intra-Cellular Therapies’s Q2 earnings are confirmed for Monday, August 8, 2022.

Q
Is Intra-Cellular Therapies (ITCI) going to split?
A

There is no upcoming split for Intra-Cellular Therapies.

Q
What sector and industry does Intra-Cellular Therapies (ITCI) operate in?
A

Intra-Cellular Therapies is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.